← Back to Search

Transcranial direct electrical stimulation (tDCS) for Neuropathic Pain

N/A
Waitlist Available
Led By Eva Widerstrom-Noga, Phd
Research Sponsored by University of Miami
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline, up to two weeks
Awards & highlights

Summary

This trial is testing a combination of two treatments, Bodily Illusion (BI) and a small electrical current, to help people with neuropathic pain. BI tricks the brain into feeling the body differently to reduce pain, while the electrical current changes brain activity to lessen pain. The goal is to find new ways to treat pain that doesn't respond well to regular medications.

Eligible Conditions
  • Neuropathic Pain

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline, up to two weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline, up to two weeks for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Change in Neuropathic Pain Severity
Change in Performance of Body Part Processing
Secondary study objectives
Change in Sensory Thresholds

Trial Design

2Treatment groups
Experimental Treatment
Placebo Group
Group I: BI-TDCS Stimulation GroupExperimental Treatment2 Interventions
Participants in this group will receive the BI and TDCS interventions for 10 sessions over two weeks.
Group II: BI-TDCS (Sham) Stimulation GroupPlacebo Group2 Interventions
Participants in this group will receive the BI and TDCS (Sham) interventions for 10 sessions over two weeks.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Transcranial direct electrical stimulation (tDCS)
2021
N/A
~10

Find a Location

Who is running the clinical trial?

University of MiamiLead Sponsor
935 Previous Clinical Trials
422,209 Total Patients Enrolled
3 Trials studying Neuropathic Pain
73 Patients Enrolled for Neuropathic Pain
FloridaOTHER
9 Previous Clinical Trials
1,076 Total Patients Enrolled
Eva Widerstrom-Noga, PhdPrincipal Investigator - University of Miami
University of Miami

Media Library

Bodily Illusions (BI) Procedure Clinical Trial Eligibility Overview. Trial Name: NCT04578574 — N/A
Neuropathic Pain Research Study Groups: BI-TDCS Stimulation Group, BI-TDCS (Sham) Stimulation Group
Neuropathic Pain Clinical Trial 2023: Bodily Illusions (BI) Procedure Highlights & Side Effects. Trial Name: NCT04578574 — N/A
Bodily Illusions (BI) Procedure 2023 Treatment Timeline for Medical Study. Trial Name: NCT04578574 — N/A
~2 spots leftby Sep 2025